English appeals court overturns Regeneron transgenic mice decision

29-03-2018

English appeals court overturns Regeneron transgenic mice decision

dra_schwartz / iStockphoto.com

The English Court of Appeal has reversed a finding that two of Regeneron’s European patents covering transgenic mice were insufficient. 


Regeneron, Kymab, Novo Nordisk, English Court of Appeal, transgenic mice, European patents, Mr Justice Carr, biotechnology


LSIPR